- Home
- DATS vs PMN Comparison
DATS vs PMN Comparison
Compare DATS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- PMN
- Stock Information
- Founded
- DATS 2014
- PMN 2004
- Country
- DATS United States
- PMN Canada
- Employees
- DATS N/A
- PMN N/A
- Industry
- DATS Computer Software: Prepackaged Software
- PMN Pharmaceuticals and Biotechnology
- Sector
- DATS Technology
- PMN Health Care
- Exchange
- DATS Nasdaq
- PMN Nasdaq
- Market Cap
- DATS 13.4M
- PMN 16.0M
- IPO Year
- DATS 2021
- PMN N/A
- Fundamental
- Price
- DATS $2.66
- PMN $0.63
- Analyst Decision
- DATS
- PMN Strong Buy
- Analyst Count
- DATS 0
- PMN 3
- Target Price
- DATS N/A
- PMN $4.33
- AVG Volume (30 Days)
- DATS 88.3K
- PMN 16.6M
- Earning Date
- DATS 08-22-2025
- PMN 08-19-2025
- Dividend Yield
- DATS N/A
- PMN N/A
- EPS Growth
- DATS N/A
- PMN N/A
- EPS
- DATS N/A
- PMN N/A
- Revenue
- DATS $388.00
- PMN N/A
- Revenue This Year
- DATS N/A
- PMN N/A
- Revenue Next Year
- DATS N/A
- PMN N/A
- P/E Ratio
- DATS N/A
- PMN N/A
- Revenue Growth
- DATS N/A
- PMN N/A
- 52 Week Low
- DATS $1.11
- PMN $0.38
- 52 Week High
- DATS $9.34
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- DATS 55.66
- PMN 48.45
- Support Level
- DATS $2.25
- PMN $0.77
- Resistance Level
- DATS $2.46
- PMN $1.06
- Average True Range (ATR)
- DATS 0.14
- PMN 0.11
- MACD
- DATS 0.01
- PMN -0.04
- Stochastic Oscillator
- DATS 87.00
- PMN 16.92
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.